Deadly toxic algae bloom causing sea lions to become sick, violent
The Brief
A toxic algae bloom is causing sea lions and other mammals and birds to become sick.
Domoic acid toxicity is caused by ocean blooms of algae called Harmful Algal Blooms. The toxin causes neurological issues in seabirds and mammals that eat anchovies, sardines, and crustaceans that have eaten the toxic algae.
The condition is known to cause seizures, stillbirths, and even violence in some sea lions.
SAN PEDRO, Calif. - A deadly toxin is causing several sea mammals and birds to fall ill or even die.
Domoic acid (DA) toxicity is caused by ocean blooms of algae called Harmful Algal Blooms (HABs). The toxin causes neurological issues in seabirds and mammals that eat anchovies, sardines, and crustaceans that have eaten the toxic algae. The toxin causes severe neurological symptoms, including tremors, seizures, stillbirths, and even violence, according to the International Bird Rescue.
The condition is treatable, but sick animals are flooding marine mammal care centers up and down the coast.
It's killing birds, dolphins, sea lions, and turtles.
To complicate the crisis, health experts say the symptoms can resemble those caused by bird flu and protozoal encephalitis.
What they're saying
A sick sea lion delivered her fetus at the Marine Mammal Care Center in San Pedro. Unfortunately, the pup won't make it…but it's mama's only chance, according to Veterinarian Dr. Alissa Deming.
"The only way to flush the toxin out of the mom and make sure we're able to save her is to induce premature labor and clear that fetus and the amniotic fluid out. And unfortunately, these fetuses are too early on gestation to be able to survive outside the mother, so our only option for them is humane euthanasia," Dr. Deming told FOX 11.
Experts say this is the worst toxic algae bloom to hit the Southern California coast, and it's currently in its fifth week.
"It's called Sudanecha and it produces domoic acid which is a toxin that gets ingested in the food system through little fish that eat algae. Bigger fish eat them and then sea lions and dolphins in particular are affected by this that eat the fish," said Marine Mammal Care Center CEO John Warner.
The longer the bloom, the more they ingest, the worse the symptoms. Experts say it's so neurologically compromising that it can cause violent behaviors in sickened mammals.
A surfer in Oxnard said a sea lion charged at him seven times, bitting his bottom. He's now out of the ER and in physical therapy.
Warner calls the encounter "uncharacteristic" even under these conditions.
"These are still the lovely, loveable cuddle-puddle sea lions that we have come to know and love but unfortunately, they're sick."
They say the chances of an animal surviving from DA is about 65%.
International Bird Rescue is currently receiving birds affected by the toxin every day. Affected species include Brown Pelicans, Western Grebes, Brandt's Cormorants and Red-throated Loons.
Experts believe the retardant used in the recent LA wildfires may be a contributor to the disease, and it's already been proven in fresh water.
What you can do
Beachgoers are urged to remain cautious when approaching sick or dead seabirds. The public can reach out for assistance to the organization's volunteer-staffed Bird HelpLine: 1-866-SOS-BIRD (866-767-2473).
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 days ago
- Yahoo
New York man accused of strangling, stabbing woman in front of child: DA
SUFFOLK COUNTY, N.Y. (PIX11) – A Long Island man is accused of strangling and stabbing his girlfriend in front of her child with developmental disabilities, a Long Island District Attorney announced Wednesday. 'Domestic violence causes deep and lasting harm,' said District Attorney Raymond A. Tierney. 'My office is here to stand with survivors and take strong action against abusers.' More Local News The DA did not name the accused to protect the identity of his victims. The district attorney's office said that the defendant is a 33-year-old male from Coram, N.Y.. According to a police investigation, the defendant and his girlfriend were staying in a Long Island hotel when they got into a fight in May 2025. The defendant allegedly began punching his girlfriend repeatedly in her head and body, authorities said. Throughout the assault, which lasted hours, he also stabbed the victim with a pen and strangled her with such force that he fractured a small bone in her neck, authorities said. The victim also sustained a laceration to her liver due to the abuse. The beating stopped when other guests at the hotel called the front desk to report the incident to the police. Responding officers observed severe bruising and swelling on the victim's face, leading to the defendant's arrest. The victim was taken to a local hospital to be treated for her injuries, police said. The defendant was charged with strangulation, assault, endangering a physically disabled person and endangering a child. The unnamed defendant is due back in court on July 2. Matthew Euzarraga is a multimedia journalist from El Paso, Texas. He has covered local news and LGBTQIA topics in the New York City Metro area since 2021. He joined the PIX11 Digital team in 2023. You can see more of his work here. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
3 days ago
- Yahoo
MetaVia Announces Poster Presentation on DA-1241 at the ADA's 85th Scientific Sessions
CAMBRIDGE, Mass., June 4, 2025 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that an abstract highlighting pre-clinical data on DA-1241, a novel G-Protein-Coupled Receptor 119 (GPR119) agonist, has been accepted for a poster presentation at the American Diabetes Association's 85th Scientific Sessions, taking place June 20-23, 2025 at the McCormick Place Convention Center in Chicago, Illinois. Title: Additive Hepatoprotective Effects of DA-1241, a GPR119 Agonist, in Combination with Efruxifermin in a Diet-Induced Obese and Biopsy-Confirmed Mouse Model of MASH Presenting Author: Yuna Chae, Lead Research Scientist, Dong-A ST Research Center Abstract Control Number: 2025-LB-6450 Session: 22-C Integrated Physiology—Liver Presentation Date: Sunday, June 22, 2025 Presentation Time: 12:30-1:30 pm CT A copy of the poster will be available on the Posters section of the MetaVia website after the presentation. Additionally, the poster will be published online on the journal, Diabetes®, website. About DA-1241DA-1241 is a novel G-Protein-Coupled Receptor 119 (GPR119) agonist with development optionality as a standalone and/or combination therapy for both MASH and type 2 diabetes (T2D). Agonism of GPR119 in the gut promotes the release of key gut peptides GLP-1, GIP, and PYY. These peptides play a further role in glucose metabolism, lipid metabolism and weight loss. DA-1241 has beneficial effects on glucose, lipid profile and liver inflammation, supported by potential efficacy demonstrated during in vivo preclinical studies. The therapeutic potential of DA-1241 has been demonstrated in multiple pre-clinical animal models of MASH and T2D where DA-1241 reduced hepatic steatosis, inflammation, fibrosis, and improved glucose control. Furthermore, in Phase 1a, 1b and 2a trials, DA-1241 was well tolerated in both healthy volunteers and those with T2DM. In a Phase 2a clinical study, DA-1241 demonstrated direct hepatic action in addition to its glucose lowering effects. About MetaViaMetaVia Inc. is a clinical-stage biotechnology company focused on transforming cardiometabolic diseases. The company is currently developing DA-1726 for the treatment of obesity, and is developing DA-1241 for the treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH). DA-1726 is a novel oxyntomodulin (OXM) analogue that functions as a glucagon-like peptide-1 receptor (GLP1R) and glucagon receptor (GCGR) dual agonist. OXM is a naturally-occurring gut hormone that activates GLP1R and GCGR, thereby decreasing food intake while increasing energy expenditure, thus potentially resulting in superior body weight loss compared to selective GLP1R agonists. In a Phase 1 multiple ascending dose (MAD) trial in obesity, DA-1726 demonstrated best-in-class potential for weight loss, glucose control, and waist reduction. DA-1241 is a novel G-protein-coupled receptor 119 (GPR119) agonist that promotes the release of key gut peptides GLP-1, GIP, and PYY. In pre-clinical studies, DA-1241 demonstrated a positive effect on liver inflammation, lipid metabolism, weight loss, and glucose metabolism, reducing hepatic steatosis, hepatic inflammation, and liver fibrosis, while also improving glucose control. In a Phase 2a clinical study, DA-1241 demonstrated direct hepatic action in addition to its glucose lowering effects. For more information, please visit Contacts: MetaViaMarshall H. WoodworthChief Financial Officer+ Rx Communications GroupMichael Miller+1-917-633-6086mmiller@ View original content to download multimedia: SOURCE MetaVia Inc.
Yahoo
31-05-2025
- Yahoo
What's really going on with Lake Erie? OSU expert breaks it down June 10
The Ohio State University at Marion will host a community lecture on Lake Erie. The event is part of the Buckeye Talks on Tap series and will feature Christopher Winslow, Ph.D., the director of Ohio Sea Grant and Stone Laboratory. The lecture, titled 'The State of Lake Erie: Nutrients and Harmful Algal Blooms,' is scheduled for 5:30 pm. Tuesday, June 10, at Bucci's Italian Scratch Kitchen. Lake Erie plays a crucial role in Ohio's economy, transportation, recreation and tourism. It also serves as a drinking water source for millions of residents, according to an announcement. Winslow will discuss nutrient sources affecting Lake Erie, including agricultural nutrient losses and best management practices. He also will address strategies for achieving a 40% reduction in phosphorus, as well as gaps in information and research needs. Winslow coordinates research, education and outreach efforts related to Lake Erie in collaboration with various state and federal agencies and universities. He holds a master's and doctorate from Bowling Green State University and a bachelor's degree from Ohio University. Before joining The Ohio State University, he served as an instructor at Bowling Green State University from 2002 to 2009 and as an assistant professor at Kutztown University of Pennsylvania from 2009 to 2011. Buckeye Talks on Tap takes place the second Tuesday of each month at Bucci's Italian Scratch Kitchen, 320 W. Center St., Marion. Doors will open at 5 p.m., with the lecture starting at 5:30 p.m. An open discussion will follow at 6 p.m. This story was created by Jane Imbody, jimbody@ with the assistance of Artificial Intelligence (AI). Journalists were involved in every step of the information gathering, review, editing and publishing process. Learn more at or share your thoughts at with our News Automation and AI team. This article originally appeared on Marion Star: Lake Erie future at stake - join the conversation in Marion June 10